Literature DB >> 27084632

Spot Scanning and Passive Scattering Proton Therapy: Relative Biological Effectiveness and Oxygen Enhancement Ratio in Cultured Cells.

Hiromitsu Iwata1, Hiroyuki Ogino2, Shingo Hashimoto3, Maho Yamada4, Hiroki Shibata5, Keisuke Yasui5, Toshiyuki Toshito6, Chihiro Omachi6, Kotoha Tatekawa7, Yoshihiko Manabe8, Jun-Etsu Mizoe2, Yuta Shibamoto8.   

Abstract

PURPOSE: To determine the relative biological effectiveness (RBE), oxygen enhancement ratio (OER), and contribution of the indirect effect of spot scanning proton beams, passive scattering proton beams, or both in cultured cells in comparison with clinically used photons. METHODS AND MATERIALS: The RBE of passive scattering proton beams at the center of the spread-out Bragg peak (SOBP) was determined from dose-survival curves in 4 cell lines using 6-MV X rays as controls. Survival of 2 cell lines after spot scanning and passive scattering proton irradiation was then compared. Biological effects at the distal end region of the SOBP were also investigated. The OER of passive scattering proton beams and 6 MX X rays were investigated in 2 cell lines. The RBE and OER values were estimated at a 10% cell survival level. The maximum degree of protection of radiation effects by dimethyl sulfoxide was determined to estimate the contribution of the indirect effect against DNA damage. All experiments comparing protons and X rays were made under the same biological conditions.
RESULTS: The RBE values of passive scattering proton beams in the 4 cell lines examined were 1.01 to 1.22 (average, 1.14) and were almost identical to those of spot scanning beams. Biological effects increased at the distal end of the SOBP. In the 2 cell lines examined, the OER was 2.74 (95% confidence interval, 2.56-2.80) and 3.08 (2.84-3.11), respectively, for X rays, and 2.39 (2.38-2.43) and 2.72 (2.69-2.75), respectively, for protons (P<.05 for both cells between X rays and protons). The maximum degree of protection was significantly higher for X rays than for proton beams (P<.05).
CONCLUSIONS: The RBE values of spot scanning and passive scattering proton beams were almost identical. The OER was lower for protons than for X rays. The lower contribution of the indirect effect may partly account for the lower OER of protons.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27084632     DOI: 10.1016/j.ijrobp.2016.01.017

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  17 in total

1.  Combined effects of cisplatin and photon or proton irradiation in cultured cells: radiosensitization, patterns of cell death and cell cycle distribution.

Authors:  Hiromitsu Iwata; Tsuyoshi Shuto; Shunsuke Kamei; Kohei Omachi; Masataka Moriuchi; Chihiro Omachi; Toshiyuki Toshito; Shingo Hashimoto; Koichiro Nakajima; Chikao Sugie; Hiroyuki Ogino; Hirofumi Kai; Yuta Shibamoto
Journal:  J Radiat Res       Date:  2020-11-16       Impact factor: 2.724

2.  Transient increases in serum α fetoprotein and protein induced by vitamin K antagonist II levels following proton therapy does not necessarily indicate progression of hepatocellular carcinoma.

Authors:  Maiko Yoshida; Hiroyuki Ogino; Hiromitsu Iwata; Yukiko Hattori; Shingo Hashimoto; Koichiro Nakajima; Shigeru Sasaki; Masaki Hara; Yoshitaka Sekido; Jun-Etsu Mizoe; Yuta Shibamoto
Journal:  Oncol Lett       Date:  2019-01-11       Impact factor: 2.967

3.  Acute toxicity of image-guided hypofractionated proton therapy for localized prostate cancer.

Authors:  Koichiro Nakajima; Hiromitsu Iwata; Hiroyuki Ogino; Yukiko Hattori; Shingo Hashimoto; Mikiko Nakanishi; Toshiyuki Toshito; Yukihiro Umemoto; Shoichiro Iwatsuki; Yuta Shibamoto; Jun-Etsu Mizoe
Journal:  Int J Clin Oncol       Date:  2017-11-02       Impact factor: 3.402

4.  Evaluation of dosimetric advantages of using patient-specific aperture system with intensity-modulated proton therapy for the shallow depth tumor.

Authors:  Keisuke Yasui; Toshiyuki Toshito; Chihiro Omachi; Kensuke Hayashi; Kenichiro Tanaka; Kumiko Asai; Akira Shimomura; Rie Muramatsu; Naoki Hayashi
Journal:  J Appl Clin Med Phys       Date:  2017-11-27       Impact factor: 2.102

5.  Prospective study to evaluate the safety of the world-first spot-scanning dedicated, small 360-degree gantry, synchrotron-based proton beam therapy system.

Authors:  Kentaro Nishioka; Anussara Prayongrat; Kota Ono; Shunsuke Onodera; Takayuki Hashimoto; Norio Katoh; Tetsuya Inoue; Rumiko Kinoshita; Koichi Yasuda; Takashi Mori; Rikiya Onimaru; Hiroki Shirato; Shinichi Shimizu
Journal:  J Radiat Res       Date:  2018-03-01       Impact factor: 2.724

6.  Long-term outcomes of proton therapy for prostate cancer in Japan: a multi-institutional survey of the Japanese Radiation Oncology Study Group.

Authors:  Hiromitsu Iwata; Hitoshi Ishikawa; Masaru Takagi; Tomoaki Okimoto; Sigeyuki Murayama; Tetsuo Akimoto; Hitoshi Wada; Takeshi Arimura; Yoshitaka Sato; Masayuki Araya; Jun-Etsu Mizoe; Masahiko Gosho; Katsumasa Nakamura; Hiroki Shirato; Hideyuki Sakurai
Journal:  Cancer Med       Date:  2018-02-14       Impact factor: 4.452

7.  Proton therapy for non-squamous cell carcinoma of the head and neck: planning comparison and toxicity.

Authors:  Hiromitsu Iwata; Toshiyuki Toshito; Kensuke Hayashi; Maho Yamada; Chihiro Omachi; Koichiro Nakajima; Yukiko Hattori; Shingo Hashimoto; Yo Kuroda; Yoshihide Okumura; Jun-Etsu Mizoe; Hiroyuki Ogino; Yuta Shibamoto
Journal:  J Radiat Res       Date:  2019-10-23       Impact factor: 2.724

8.  Difference in the relative biological effectiveness and DNA damage repair processes in response to proton beam therapy according to the positions of the spread out Bragg peak.

Authors:  Hidehiro Hojo; Takeshi Dohmae; Kenji Hotta; Ryosuke Kohno; Atsushi Motegi; Atsushi Yagishita; Hideki Makinoshima; Katsuya Tsuchihara; Tetsuo Akimoto
Journal:  Radiat Oncol       Date:  2017-07-03       Impact factor: 3.481

9.  Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer.

Authors:  Koichiro Nakajima; Hiromitsu Iwata; Hiroyuki Ogino; Yukiko Hattori; Shingo Hashimoto; Toshiyuki Toshito; Kensuke Hayashi; Kenji Akita; Fumiya Baba; Katsumi Nakamae; Jun-Etsu Mizoe; Yuta Shibamoto
Journal:  Radiat Oncol       Date:  2018-10-11       Impact factor: 3.481

10.  Phantom design and dosimetric characterization for multiple simultaneous cell irradiations with active pencil beam scanning.

Authors:  Monika Clausen; Suphalak Khachonkham; Sylvia Gruber; Peter Kuess; Rolf Seemann; Barbara Knäusl; Elisabeth Mara; Hugo Palmans; Wolfgang Dörr; Dietmar Georg
Journal:  Radiat Environ Biophys       Date:  2019-09-20       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.